Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-02 Sale | 2024-04-03 4:13 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 1,357 | $9.88 | $13,407 | 117,004 (Direct) | View |
| 2024-02-21 Sale | 2024-02-22 4:36 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 3,966 | $7.45 | $29,547 | 118,361 (Direct) | View |
| 2024-01-17 Sale | 2024-01-19 4:34 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 2,543 | $7.15 | $18,182 | 72,327 (Direct) | View |
| 2023-04-03 Sale | 2023-04-05 5:02 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 1,259 | $7.83 | $9,858 | 71,617 (Direct) | View |
| 2023-03-20 Sale | 2023-03-22 4:48 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 3,654 | $7.76 | $28,355 | 72,876 (Direct) | View |
| 2023-03-15 Sale | 2023-03-17 4:37 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 15,373 | $8.2 | $126,059 | 76,530 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 4:53 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 2,188 | $9.8487 | $21,549 | 51,903 (Direct) | View |
| 2022-04-04 Sale | 2022-04-06 4:34 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 1,527 | $8.25 | $12,598 | 52,060 (Direct) | View |
| 2022-03-21 Sale | 2022-03-23 6:40 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 4,413 | $8.2945 | $36,604 | 53,587 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-09 Option Award | 2024-02-16 5:03 pm | N/A 2034-02-09 | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 150,000 | $0 | 222,327 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-22 8:52 pm | N/A 2033-02-17 | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 120,000 | $0 | 171,903 (Direct) | View |
| 2022-02-07 Option Award | 2022-02-09 4:28 pm | N/A 2032-02-07 | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 65,000 | $0 | 65,000 (Direct) | View |
Ownership | 2022-02-09 4:26 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 0 | $0 | 254,500 (Direct) | View |